Alcohol and Tobacco Consumption in Patients With Head and Neck Cancer : Interest of an Addiction Support
NCT ID: NCT01652456
Last Updated: 2018-01-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2012-10-31
2017-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Alcohol and Tobacco Consumption in Patients With Head and Neck or Lung Cancer : Interest of an Addiction Treatment
NCT02540174
Optimization of Smoking Cessation Strategies Concurrent With Treatment of Tobacco Related Malignancies
NCT02048917
Alcohol Cessation Among Head and Neck Cancer Survivors
NCT05570851
Cancer Risk Reduction Through Combined Treatment for Tobacco and Alcohol Use
NCT00799669
Smoking Relapse-Prevention Intervention for Cancer Patients
NCT01630161
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group A
Addiction support
one consultation with an addiction specialist
Group B
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Addiction support
one consultation with an addiction specialist
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* first support
* 18 ≤ age ≤ 60
* lives in Lille Metropolis
* having an addiction to alcohol and tobacco
* covered by health insurance
* signed informed consent
Exclusion Criteria
* mesothelioma and oesophageal cancer
* unable to undergo trail medical follow up (geographical, social and psychological reasons)
* pregnant or nursing woman
* patient under guardianship
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Oscar Lambret
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Corinne VANNIMENUS, MD
Role: STUDY_DIRECTOR
Centre Hospitalier Régional et Universitaire
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Oscar Lambret Center
Lille, , France
Centre Hospitalier Régional et Universitaire - Hopital CALMETTE
Lille, , France
Centre Hospitalier Régional et Universitaire - Hopital HURIEZ
Lille, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ALTAKRA - 1205
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.